Role of CA 19.9 in the Management of Resectable Pancreatic Cancer: State of the Art and Future Perspectives.
Alessandro CoppolaVincenzo La VaccaraTommaso FarolfiMichele FioreRoberto CammarataSara RamellaRoberto CoppolaDamiano CaputoPublished in: Biomedicines (2022)
The potential of CA 19.9 must be fully explored in order to standardize its role in the "biological staging" of patients with resectable pancreatic cancer.